Home › Funds › Soleus Capital Management, L.P. › PRCT
Soleus Capital Management, L.P. position in PRCT
PROCEPT BIOROBOTICS CORP · Health Care
Soleus Capital Management, L.P. reported holding 1,003,000 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q2 2026 13F filing — a position valued at US$22.6M, representing 0.78% of its reported portfolio and ranking #35 among its reported holdings. Soleus Capital Management, L.P. has disclosed PRCT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s PRCT position evolved
Soleus Capital Management, L.P. first disclosed a stake in PRCT in Q1 2026 at 160,000 shares (US$4.0M). The position peaked in Q2 2026 at 1,003,000 shares, worth US$22.6M. Across 2 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,003,000 shares valued at US$22.6M — an increase of 843,000 shares quarter over quarter.. Notable position changes include a 527% increase in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 160.00K | $4.00M | New |
| Q2 2026 | 1.00M | $22.65M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRCT and 13F data
PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 17 other funds we track also report a position in PRCT. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held PRCT?
Soleus Capital Management, L.P. has disclosed PRCT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Soleus Capital Management, L.P.'s current position in PRCT?
As of Q2 2026, Soleus Capital Management, L.P. holds 1.00M shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $22.65M, representing 0.78% of its reported portfolio and ranking #35.
Has Soleus Capital Management, L.P. been buying or selling PRCT?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. increased its position in PRCT. The position peaked in Q2 2026 at 1.00M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.